GANT61 and anti-PDL1 mAb combination therapy effectively inhibited tumor growth and prolonged the survival rate of mice compared with the control and monotherapy groups (Fig. 7E–G, Supplementary Fig. 5A). This evidence concerns the gene CD274 and neoplasm.